Application Nr Approved Date Route Status External Links
NDA021923 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Nexavar Is A Kinase Inhibitor Indicated For The Treatment Of • Unresectable Hepatocellular Carcinoma ( 1.1 ) • Advanced Renal Cell Carcinoma ( 1.2 ) • Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma (Dtc) Refractory To Radioactive Iodine Treatment ( 1.3 ) 1.1 Hepatocellular Carcinoma Nexavar ® Is Indicated For The Treatment Of Patients With Unresectable Hepatocellular Carcinoma (Hcc). 1.2 Renal Cell Carcinoma Nexavar Is Indicated For The Treatment Of Patients With Advanced Renal Cell Carcinoma (Rcc). 1.3 Differentiated Thyroid Carcinoma Nexavar Is Indicated For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma (Dtc) That Is Refractory To Radioactive Iodine Treatment.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Sorafenib SORAFENIB ZINC1493878

Comments